G J Mufti

7.3k citations

119 papers · 4.8k indexed · 1 hit paper · h-index 36

Hematology top 0.2%
Oncology top 2%
Molecular Biology top 10%
Immunology top 2%
Genetics top 0.5%

Co-authors: David Oscier Terry J. Hamblin Stephan A. Grupp Philippe Duchâteau Laurent Poirot Stéphane Depil Antonio Pagliuca Jasper Stevens
Topics: Acute Myeloid Leukemia Research (54 papers)Hematopoietic Stem Cell Transplantation (28 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers)
Cited by: Hematology Genetics Oncology
Journals: The Lancet Journal of Clinical Oncology Blood
Partner nations: United Kingdom United States Japan

In The Last Decade

G J Mufti

116 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

‘Off-the-shelf’ allogeneic CAR T cells: development and challenges

2020 824 citations G J Mufti et al. profile →

Peers

Countries citing papers authored by G J Mufti

Since Specialization

Citations

This map shows the geographic impact of G J Mufti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G J Mufti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G J Mufti more than expected).

Fields of papers citing papers by G J Mufti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G J Mufti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G J Mufti. The network helps show where G J Mufti may publish in the future.

Co-authorship network of co-authors of G J Mufti

This figure shows the co-authorship network connecting the top 25 collaborators of G J Mufti. A scholar is included among the top collaborators of G J Mufti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G J Mufti. G J Mufti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical modeling of myelodysplastic syndromes 2017 ·Leukemia ·Kevin Rouault‐Pierre,Syed A. Mian,(unknown),Ander Abarrategi,(unknown),Alexander Smith,Abidali Mohamedali,Steven Best,(unknown),Austin Kulasekararaj,Lionel Adès,Christine Chomienne,Pierre Fenaux,Christine Dosquet,G J Mufti,Dominique Bonnet	24
2	Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes 2015 ·Leukemia ·David A. Sallman,Rami S. Komrokji,Christine Vaupel,Thomas Cluzeau,Susan Geyer,Kathy L. McGraw,Najla H. Al Ali,Jeffrey E. Lancet,Matthew J. McGinniss,Shareef Nahas,Alexander Smith,Austin Kulasekararaj,G J Mufti,Alan F. List,Jeff Hall,Eric Padron	137
3	The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT 2012 ·Bone Marrow Transplantation ·Sebastian Giebel,Myriam Labopin,Mohamad Mohty,G J Mufti,Dietger Niederwieser,J.J. Cornelissen,Jeroen J. W. M. Janssen,Nöel Milpied,Lars L. Vindeløv,Eefke Petersen,R Arnold,Andrea Bacigalupo,Didier Blaise,Charles Craddock,A Nagler,Francesco Frassoni,Maria Saduś‐Wojciechowska,Vanderson Rocha	22
4	Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis 2011 ·Leukemia Research ·(unknown),Zi Yi Lim,Pramila Krishnamurthy,Victoria Potter,(unknown),(unknown),(unknown),N C Lea,Michelle Kenyon,J. Marsh,Aloysius Ho,G J Mufti,Antonio Pagliuca	1
5	Reducing MCM levels in human primary T cells during the G0→G1 transition causes genomic instability during the first cell cycle 2010 ·Oncogene ·(unknown),Terry J. Gaymes,(unknown),Constantinos Chronis,Barbara Czepulkowski,(unknown),G J Mufti,Edward M. Marcotte,N. Shaun B. Thomas	36
6	Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be? 2009 ·Haematologica ·Sergio Querol,G J Mufti,Steven G. E. Marsh,Antonio Pagliuca,Ann‐Margaret Little,(unknown),Rosemary Jeffery,Joan Garcı́a,J M Goldman,J. Alejandro Madrigal	47
7	Drug rash with eosinophilia and systemic symptoms and graft-versus-host disease developing sequentially in a patient 2008 ·Clinical and Experimental Dermatology ·J. Natkunarajah,Katherine A. Watson,Salvador J. Díaz‐Cano,G J Mufti,Anthony du Vivier,D. Creamer	6
8	Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London – 2005 2006 ·Bone Marrow Transplantation ·Rafael F. Duarte,DH Pamphilon,J Cornish,Bronwen E. Shaw,D Samson,Charles Craddock,D I Marks,G J Mufti,R Powles,Jane F. Apperley,J. Alejandro Madrigal,J M Goldman	2
9	Reduced-intensity rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation for follicular lymphoma is feasible and induces durable molecular remissions 2003 ·Bone Marrow Transplantation ·Aloysius Ho,Stephen Devereux,G J Mufti,Antonio Pagliuca	19
10	The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanoma 1996 ·British Journal of Cancer ·(unknown),D. Christopher Darling,Joop Gäken,W J R Hirst,(unknown),Marcel Kuiper,Paul Towner,S. Humphreys,Farzin Farzaneh,G J Mufti	16
11	Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) 1996 ·Leukemia Research ·J Stephenson,Barbara Czepulkowski,W J R Hirst,G J Mufti	44
12	High-dose methylprednisolone, low-dose cytosine arabinoside, and mitoxantrone in children with myelodysplastic syndromes. 1995 ·PubMed ·Gönül Hiçsönmez,(unknown),Tülin Revide Şaylı,(unknown),(unknown),Namık Yaşar Özbek,G J Mufti	16
13	VAPEC-B chemotherapy in the treatment of aggressive non-Hodgkin's lymphoma: A retrospective analysis of 45 patients 1995 ·Clinical Oncology ·(unknown),(unknown),K W Pettingale,A.B.W. Nethersell,H.J. Dobbs,(unknown),(unknown),G J Mufti	0
14	A pilot study of low‐dose recombinant human granulocyte‐macrophage colony‐stimulating factor in chronic neutropenia 1993 ·British Journal of Haematology ·Richard Kaczmarski,(unknown),A. Lakhani,Elizabeth Harvey,G J Mufti	11
15	MANAGEMENT OF MYELODYSPLASTIC SYNDROMES 1993 ·British Journal of Haematology ·W J R Hirst,G J Mufti	17
16	Myelofibrosis in primary myelodysplastic syndromes: a clinico‐morphological study of 10 cases 1989 ·British Journal of Haematology ·Antonio Pagliuca,D. Mark Layton,A. Manoharan,S. Gordon,(unknown),G J Mufti	77
17	Pyogenic abscesses in the myelodysplastic syndrome. 1989 ·BMJ ·Patrick Williamson,David Oscier,G J Mufti,Terry J. Hamblin	16
18	Bleomycin‐detectable iron in serum from leukaemic patients before and after chemotherapy Therapeutic implications for treatment with oxidant‐generating drugs 1988 ·FEBS Letters ·Barry Halliwell,Okezie I. Aruoma,G J Mufti,Adrian Bomford	74
19	Differentiation induction in myelodysplasia and acute myeloid leukaemia: Use of synergistic drug combinations 1987 ·Leukemia Research ·G. E. Francis,G J Mufti,S. Knowles,J. J. Berney,(unknown),Lorna M. Secker‐Walker,Terry J. Hamblin	17
20	Monocytic skin infiltration in chronic myelomonocytic leukaemia 1986 ·Clinical & Laboratory Haematology ·J. A. Copplestone,David Oscier,G J Mufti,Terry J. Hamblin	25

About G J Mufti

G J Mufti is a scholar working on Hematology, Genetics and Oncology, having authored 119 papers that have together received 4.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (54 papers), Hematopoietic Stem Cell Transplantation (28 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers). The work is most often cited by research in Hematology (2.8k citations), Genetics (988 citations) and Oncology (1.4k citations). G J Mufti has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include David Oscier, Terry J. Hamblin, Stephan A. Grupp, Philippe Duchâteau, Laurent Poirot, Stéphane Depil, Antonio Pagliuca, Jasper Stevens, David Machin and Aloysius Ho. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact